Your browser doesn't support javascript.
loading
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial.
Han, H S; Arun, B K; Kaufman, B; Wildiers, H; Friedlander, M; Ayoub, J P; Puhalla, S L; Bach, B A; Kundu, M G; Khandelwal, N; Feng, D; Bhattacharya, S; Maag, D; Ratajczak, C K; Diéras, V.
Afiliação
  • Han HS; Moffitt Cancer Center, Tampa, USA. Electronic address: hyo.han@moffitt.org.
  • Arun BK; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Kaufman B; Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel.
  • Wildiers H; University Hospitals Leuven, Leuven, Belgium.
  • Friedlander M; Prince of Wales Clinical School UNSW and Prince of Wales Hospital, Sydney, Australia.
  • Ayoub JP; Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
  • Puhalla SL; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, USA.
  • Bach BA; AbbVie Inc., North Chicago, USA.
  • Kundu MG; AbbVie Inc., North Chicago, USA.
  • Khandelwal N; AbbVie Inc., North Chicago, USA.
  • Feng D; AbbVie Inc., North Chicago, USA.
  • Bhattacharya S; AbbVie Inc., North Chicago, USA.
  • Maag D; AbbVie Inc., North Chicago, USA.
  • Ratajczak CK; AbbVie Inc., North Chicago, USA.
  • Diéras V; Institut Curie, Paris, France; Centre Eugène Marquis, Rennes, France.
Ann Oncol ; 33(3): 299-309, 2022 03.
Article em En | MEDLINE | ID: mdl-34861374
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article